JP2025170230A5 - - Google Patents

Info

Publication number
JP2025170230A5
JP2025170230A5 JP2025101576A JP2025101576A JP2025170230A5 JP 2025170230 A5 JP2025170230 A5 JP 2025170230A5 JP 2025101576 A JP2025101576 A JP 2025101576A JP 2025101576 A JP2025101576 A JP 2025101576A JP 2025170230 A5 JP2025170230 A5 JP 2025170230A5
Authority
JP
Japan
Prior art keywords
modified live
felv
amino acid
acid sequence
fcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025101576A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025170230A (ja
Filing date
Publication date
Priority claimed from JP2020524411A external-priority patent/JP7427585B2/ja
Application filed filed Critical
Publication of JP2025170230A publication Critical patent/JP2025170230A/ja
Publication of JP2025170230A5 publication Critical patent/JP2025170230A5/ja
Pending legal-status Critical Current

Links

JP2025101576A 2017-12-15 2025-06-17 多価ネコワクチン Pending JP2025170230A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762599401P 2017-12-15 2017-12-15
US62/599,401 2017-12-15
JP2020524411A JP7427585B2 (ja) 2017-12-15 2018-11-05 多価ネコワクチン
PCT/EP2018/080106 WO2019115090A1 (en) 2017-12-15 2018-11-05 Multivalent feline vaccine
JP2023158724A JP7742695B2 (ja) 2017-12-15 2023-09-22 多価ネコワクチン

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023158724A Division JP7742695B2 (ja) 2017-12-15 2023-09-22 多価ネコワクチン

Publications (2)

Publication Number Publication Date
JP2025170230A JP2025170230A (ja) 2025-11-18
JP2025170230A5 true JP2025170230A5 (enExample) 2025-12-05

Family

ID=64316488

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020524411A Active JP7427585B2 (ja) 2017-12-15 2018-11-05 多価ネコワクチン
JP2023158724A Active JP7742695B2 (ja) 2017-12-15 2023-09-22 多価ネコワクチン
JP2025101576A Pending JP2025170230A (ja) 2017-12-15 2025-06-17 多価ネコワクチン

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020524411A Active JP7427585B2 (ja) 2017-12-15 2018-11-05 多価ネコワクチン
JP2023158724A Active JP7742695B2 (ja) 2017-12-15 2023-09-22 多価ネコワクチン

Country Status (4)

Country Link
JP (3) JP7427585B2 (enExample)
AU (2) AU2018383915B9 (enExample)
CA (1) CA3080087A1 (enExample)
WO (1) WO2019115090A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10421790B2 (en) * 2015-12-23 2019-09-24 Intervet, Inc. Feline calicivirus vaccine
EP4149532A1 (en) 2020-05-11 2023-03-22 Intervet International B.V. Feline severe acute respiratory syndrome coronavirus 2 vaccine
CA3198118A1 (en) 2020-11-12 2022-05-19 Martijn Alexander LANGEREIS Recombinant vectors encoding chimeric coronavirus spike proteins and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066568A2 (en) * 2000-03-09 2001-09-13 Heska Corporation Use of recombinant antigens to determine the immune status of an animal
DE60130569D1 (de) 2000-08-29 2007-10-31 Wyeth Corp Verpackung von replikon-partikeln eines positiv-strängigen rna-virus
US7309495B2 (en) 2003-03-14 2007-12-18 The Regents Of The University Of California Hemorrhagic feline calicivirus
EP1751289B1 (en) * 2004-05-18 2009-01-14 Alphavax, Inc. Tc-83-derived alphavirus vectors, particles and methods
US7306807B2 (en) 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
PL2183368T3 (pl) 2007-06-21 2016-12-30 Kasety bez promotora do ekspresji alfawirusowych białek strukturalnych
US10421790B2 (en) 2015-12-23 2019-09-24 Intervet, Inc. Feline calicivirus vaccine
US10411152B2 (en) * 2016-06-27 2019-09-10 Merlin Solar Technologies, Inc. Solar cell bonding
CA3080427A1 (en) * 2017-11-06 2019-05-09 Intervet International B.V. Feline leukemia virus vaccine
AU2018380582B2 (en) * 2017-12-08 2025-08-14 Intervet International B.V. Feline calicivirus vaccine

Similar Documents

Publication Publication Date Title
JP2025170230A5 (enExample)
JPH08168381A (ja) 組換え伝染性非セグメント化陰性鎖ｒｎａウイルス
JP2019526580A5 (enExample)
NO20080046L (no) Fremgangsmater for administrering av vaksine, nye feline calicivirus, og behandlinger for a immunisere dyr mot feline paraovirus og feline herpesvirus
JP2025169249A5 (enExample)
JP7742695B2 (ja) 多価ネコワクチン
RU2012140741A (ru) Композиции рекомбинантного cdv и ее применение
JP7721604B2 (ja) ネコカリシウイルスワクチン
CA3080427A1 (en) Feline leukemia virus vaccine
JP2025169249A (ja) 狂犬病ウイルスワクチン
AU2022338199A1 (en) Utilization of micro-rna for downregulation of cytotoxic transgene expression by modified vaccinia virus ankara (mva)
McKenna et al. Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases
Zhang et al. Virus-like vesicles based on Semliki forest virus-containing rabies virus glycoprotein make a safe and efficacious rabies vaccine candidate in a mouse model
US8785411B2 (en) HIV DNA vaccine methods of use
US20050112102A1 (en) DNA vaccine compositions and methods of use
AU2018275790B2 (en) Genetically attenuated nucleic acid vaccine
US20160279229A9 (en) Viral Vaccine Vectors
RU2023114426A (ru) Поливалентная вакцина для животных семейства кошачьих
RU2020122007A (ru) Поливалентная вакцина для животных семейства кошачьих
US20220008532A1 (en) Multivalent feline vaccine
Mahr et al. Vaccinia recombinants as vaccine vectors
CN104906571B (zh) 一种用于hiv‑1 b/c亚型的预防性重组vlp疫苗及制备方法
Yang et al. Construction of nervous necrosis virus (NNV) genome-based DNA replicon vectors for the delivery of foreign antigens
CN119264229A (zh) 基于SARS-CoV-2的不同奥密克戎变异型的S蛋白的疫苗和组合物
MX2019014819A (es) Plásmido para inserción simplificada de secuencias cortas de adn en un cistrón que codifica para una proteína de cápside potyviral y método de aplicación.